Bright Minds Biosciences (DRUG)Perceptive Advisors LLC reduced its stake -72K shares

378K

Shares reported · -72K vs prior quarter

0.54%

Disclosed portfolio weight

$27.5M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 28, 2026InsiderInsider sold ~$9.79M of DRUG shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Bright Minds Biosciences

For Bright Minds Biosciences, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DRUG page.

How this filing works

• SEC Form 13F

Other disclosures at Bright Minds Biosciences

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 4Apr 30, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 13F-HRAug 14, 2025
• SEC Form 13F-HRAug 6, 2025

Everything OQRO holds on this company is on its DRUG page.